16d (edited) • General discussion
AOD-9604: The HGH Fragment That Targets Fat Without the Hormonal Downsides
This is one of my favorites to suggest when you just have that stubborn fat or you are responding to the GLP-1.
Most fat loss peptides come with trade-offs. GLP-1 agents cause muscle loss. Full HGH raises blood sugar and IGF-1. CJC/Ipamorelin stacks need careful timing and monitoring.
AOD-9604 is one of the cleaner options in the space because it was specifically engineered to do one thing: burn fat — without touching your hormonal axis.
WHAT IS IT?
AOD-9604 is hGH fragment 176-191. Monash University in Australia isolated the portion of the HGH molecule responsible for lipolysis and built a standalone peptide from it. The key finding from their research: this fragment retains the fat-burning mechanism of growth hormone but does not bind to GH receptors in the liver or muscle.
Practically, that means:
No effect on blood glucose (confirmed across multiple clinical trials)
No effect on IGF-1
No effect on natural GH production
It reached Phase 3 clinical trials for obesity treatment. The program was discontinued for commercial reasons — not safety concerns. The safety data from those trials is genuinely solid.
HOW IT WORKS
AOD-9604 stimulates beta-3 adrenergic receptors on fat cells, triggering the breakdown of stored triglycerides into free fatty acids. The effect is amplified in a fasted state, which is why the standard protocol calls for a morning injection before eating.
DOSING
5mg vial + 2.5mL BAC water = 2mg/mL (most common reconstitution)
250mcg = draw to 12.5 IU
300mcg = draw to 15 IU
500mcg = draw to 25 IU
Standard dose: 300mcg SubQ in the morning, fasted. Wait 30-60 minutes before eating.
Cycle: 12-16 weeks on, 4-6 weeks off.
Stacks well with: MK-677 (for muscle preservation), BPC-157, or alongside GLP-1 agents to target fat more specifically while managing the muscle loss problem.
BERRY’s EXPERIENCE
“AOD-9604 doesn't feel like anything — there's no stimulant effect, no noticeable shift in energy or appetite. The results appear in the mirror over weeks. I ran it at 300mcg/day for 12 weeks combined with a moderate deficit and consistent training. Abdominal fat was the most visibly reduced area, which tracks with the clinical data showing preferential visceral fat loss.”
The main pitfall: source quality. AOD is widely mislabelled and underdosed. I've seen COAs where actual AOD content was 40% of the label claim. Get third-party tested peptides with a full endotoxin panel.
This is why we send our peptides off to be tested.
2
5 comments
AOD-9604: The HGH Fragment That Targets Fat Without the Hormonal Downsides
powered by
skool.com/luxx-lounge-6140
We are here to educate, inspire and bridge the gap with wellness and medicine. Telehealth platform launching in 7 days. Share your excitement for peps
Suggested communities
Powered by